The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.
about
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@en
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@nl
type
label
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@en
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@nl
prefLabel
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@en
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@nl
P2093
P2860
P50
P1433
P1476
The neutrophil-to-lymphocyte a ...... triple negative breast cancer.
@en
P2093
Alessia Mennitto
Benvenuto Ferrari
Claudia Maggi
Claudio Vernieri
Filippo de Braud
Gabriella Mariani
Giuseppe Capri
Lucia Rinaldi
Maria Silvia Cona
Michele Prisciandaro
P2860
P356
10.1038/S41598-018-27075-Z
P407
P577
2018-06-07T00:00:00Z